Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by OttawaPeteron Feb 01, 2023 3:58pm
159 Views
Post# 35260547

RE:RE:RE:RE:Jannsen Biotech extends its partnership with BTI on xB3!!

RE:RE:RE:RE:Jannsen Biotech extends its partnership with BTI on xB3!!

narmac wrote: My source tells me its an indirect confirmation of the continued partnership. Is it material?,,,The other extensions were never mentioned to shareholders. I have not stopped trying to bring all shareholders together around these trying circumstances BTI has created. Any and all tid bits are offered. Friday will possibly tell the tale if correct. Will it make a difference to share price,,not likely,,we know the technology works,,we just dont know how to sell the news!!

Please note the pop in share price based on the spreading of this rumour --the company's finances are & have been in the toilet for a while now--  any kind of news about extensions is "good news".

If this is actually true-- if Janssen --Prothena --or any of those other guys are still in play-- why such "dire circumstances" & the terrible to SHs deal with Midatech being "the only option" as DR told several SHs.  

Something ain't right here-- I call BS  --seems more like last ditch effort for DR & BOD to save their own skin right before the voting ends. 

-Pete


 

<< Previous
Bullboard Posts
Next >>